This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Aeolus Pharmaceuticals, Inc.
Drug Names(s): manganese porphyrin, AEOL-10150
Description: AEOL 10150 is a small molecule, broad-spectrum, catalytic antioxidant specifically designed to neutralize reactive oxygen and nitrogen species. The neutralization of these species reduces oxidative stress, inflammation, and subsequent tissue damage via signaling cascades induced by radiation or chemical exposure. The compound’s mitigation of organ-specific damage induced by acute exposure to potentially lethal doses of radiation and chemical agents is based on the hypothesis, and supporting data, that these stressors initiate a pro-inflammatory cascade that disrupts organ integrity and function in a radiation or chemical dose- and time-dependent fashion. This common mechanism of action permits analysis of efficacy in multiple models of organ-specific damage.
AEOL 10150 News
Pink Sheet Medicaid price rebates
Additional information available to subscribers only: